Dostarlimab and Cobolimab in Advanced Cervical Cancer

Description

This research is being done to determine how effective dostarlimab in combination with cobolimab is in metastatic or recurrent cervical cancer.

Conditions

Cervical Cancer, Advanced Cervical Carcinoma, Metastatic Cervical Cancer, Metastatic Cervical Carcinoma, Recurrent Cervical Carcinoma

Talk to us

Study Overview

On this page

Study Details

Study overview

This research is being done to determine how effective dostarlimab in combination with cobolimab is in metastatic or recurrent cervical cancer.

A Phase 2 Study of Dostarlimab in Combination With Cobolimab in Advanced Cervical Cancer

Dostarlimab and Cobolimab in Advanced Cervical Cancer

Condition
Cervical Cancer
Intervention / Treatment

-

Contacts and Locations

Boston

Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States, 02215

Boston

Dana-Farber Cancer Institute, Boston, Massachusetts, United States, 02215

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

    Ages Eligible for Study

    18 Years to

    Sexes Eligible for Study

    FEMALE

    Accepts Healthy Volunteers

    No

    Collaborators and Investigators

    Meghan Shea,

    Meghan Shea, MD, PRINCIPAL_INVESTIGATOR, Beth Israel Deaconess Medical Center

    Study Record Dates

    2027-07-15